Contents
Blessing Hospital agreed to pay approximately $2.82 million to settle allegations that it collected Medicare and Medicaid facility payments for medically unnecessary coronary stents. The government alleged that the physician performed the unnecessary procedures and Blessing collected the facility payments. Blessing brought that billing to the government’s attention itself. For someone who sees what happens in a cath lab, the case reaches beyond the doctor’s treatment decision to the hospital revenue it generates.
The Blessing Hospital coronary stent settlement concerned the facility component of cardiac catheterization procedures performed from August 1, 2012 through August 30, 2018. The government alleged that a physician implanted unnecessary coronary arterial stents during those procedures and that Blessing obtained payment for the hospital’s part of the care.
The U.S. Attorney’s Office for the Central District of Illinois announced the agreement with the Quincy, Illinois, hospital on August 17, 2021.
Blessing made a voluntary hospital disclosure. The alleged harm reached both patients undergoing needless procedures and taxpayers funding them.
The agreement allocated nearly $2.59 million to the United States, approximately $225,000 to Illinois, and the remainder to Iowa and Missouri.
The facility component is the hospital’s payment, separate from the physician’s professional bill. That distinction puts Blessing’s unnecessary coronary stent allegations squarely inside the hospital’s own business: the government said it had paid the institution for procedures patients did not need.
In an outpatient department, Medicare pays a facility fee as well as a separate professional fee.
That is the connection a hospital billing employee, clinical reviewer or cath-lab manager may recognize. The clinical reason for the stent, the procedure report and the facility claim concern the same episode of care.
Not every stent case starts with the hospital. The EMH Regional and North Ohio Heart stent settlement began with a whistleblower who had managed EMH’s catheterization and electrophysiology laboratory. The Justice Department announced the $4,405,727 settlement on January 7, 2013.
The government alleged insufficient occlusion: patients had heart disease, but their blood vessels were not blocked enough to require the angioplasty and stent procedures performed. The disease was real. The dispute concerned what the providers did about it and billed for.
That former cath-lab manager received 15% of the recovery. The case shows why a whistleblower’s knowledge of unnecessary angioplasty and stents can matter beyond a single physician’s account of a procedure. Someone who knows the laboratory’s work may be able to connect treatment decisions across patients with the claims they produced.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. The EMH case began with an insider’s account, while Blessing’s began with the hospital’s disclosure.
In the separate Saint Joseph London case, whistleblowers alleged that the medical records and images contradicted the blockages reported by a physician. Their first amended complaint gave a concrete example of the difference:
Based on Relators’ review of the medical records and imaging, the distal left main coronary artery narrowing was no more than about 30 percent (not 70-75 percent as reported by [the physician]) and the reported narrowing of the ostium of the left anterior descending artery did not exist (not 80-90 percent as reported by [the physician]).
Whistleblowers’ first amended complaint, United States ex rel. Jones, Hollingsworth and Rukavina v. Saint Joseph Health System et al.
The allegation is about a report giving a procedure a justification that the reviewers said the images did not support. The complaint also alleged that hospital leadership failed to put in place quality assurance and peer review that would detect unnecessary procedures.
The government’s settlement announcement alleged unnecessary coronary stents, pacemakers, bypass surgeries and diagnostic catheterizations on Medicare and Medicaid patients. It also alleged that the hospital knew. For an insider, what management heard about the procedures can matter alongside what the images showed.
King’s Daughters Medical Center settled allegations that its physicians used false medical records to justify unnecessary cardiac procedures. The government alleged both unnecessary coronary stents and diagnostic catheterizations and falsification of the records supporting them. That adds a pointed question to the clinical review: who supplied the justification that reached the bill?
St. Joseph Medical Center in Towson combined different allegations in its settlement. The government alleged that eleven professional-services agreements with MidAtlantic Cardiovascular Associates paid too much, paid for work not performed or lacked a reasonable business purpose, in exchange for cardiac referrals. The settlement also covered allegedly unnecessary stents.
St. Joseph Towson’s cardiac catheterization independent review addressed the care itself. Its agreement required an outside organization to assess the necessity and appropriateness of interventional procedures, alongside a consultant’s review of peer-review practices. The response reached both the payment arrangements and the hospital’s oversight of treatment.
At Desert Regional Medical Center, the alleged unnecessary cardiac devices were loop recorders, implanted heart monitors. A former hospital employee brought that case. The connection between the procedure and the hospital’s claim extends beyond coronary stents.
The same concern appears in spinal care. CHI Franciscan and St. Joseph Tacoma settled allegations of hospital billing for spinal surgery at more levels than necessary and unnecessary spinal fusions. At Sanford Health, the government alleged that colleagues repeatedly warned about a neurosurgeon’s unnecessary procedures involving devices in which he had a financial interest, yet the hospital continued billing. Those cases put the extent of treatment, implant profits and the hospital’s response to warnings into the same conversation.
Comparing billing records with medical records can expose a difference that neither set explains alone. Types of Hospital Frauds: Nature and Methods of Prevention, published in the Journal of Forensic and Investigative Accounting in 2023, examined 80 hospital-related fraud cases drawn from Justice Department announcements. It classified 42 as fraudulent billing of medical services.
The study concluded that comparing medical and billing records could have prevented 27 of those cases, and that analyzing coding data could have helped prevent 24. The useful point for a cath-lab insider is the comparison: the clinical account and the payment account have to be read together.
The paper also explains why dividing responsibilities among employees can fail when the people involved cooperate in the fraud: once they act together, internal controls can lose their meaning.
An insider who knows where the images, procedure report and claim diverge has something concrete to discuss with us.
If you know why the images, treatment decisions and facility claims tell different stories, speak with our whistleblower experts about the stent billing you know firsthand. We connect that knowledge to a hospital fraud case and bring in whistleblower lawyers who know cardiac medical-necessity claims. Our experts stay beside you from the first conversation through the case’s resolution.